Publications Internationales

 Sampling strategy for bacteriological diagnosis of intrathoracic tuberculosis. Maitre T, Ok V, Morel F, Bonnet I, Sougakoff W, Robert J, Trosini V, Caumes E, Aubry A, Veziris N. Respir Med Res. 2021 May ;79:100825. https://doi.org/10.1016/j.resmer.20...

 Impact of the revised definition of extensively drug resistant tuberculosis. Veziris N, Bonnet I, Morel F, Guglielmetti L, Maitre T, Fournier Le Ray L, Sougakoff W, Robert J, Aubry A ; CNR MyRMA. Eur Respir J. 2021 May 6:2100641. https://doi.org/10.1183/13993003.00...

 Isoniazid-monoresistant tuberculosis in France : Risk factors, treatment outcomes and adverse events. Bachir M, Guglielmetti L, Tunesi S, Billard-Pomares T, Chiesi S, Jaffré J, Langris H, Pourcher V, Schramm F, Lemaître N, Robert J ; Isoniazid Resistance Group. Int J Infect Dis. 2021 Apr 3 ;107:86-91. https://doi.org/10.1016/j.ijid.2021...

 Defining optimal fluoroquinolone exposure against Mycobacterium tuberculosis : contribution of murine studies. Maitre T, Guglielmetti L, Veziris N. Eur Respir J. 2021 Apr 1 ;57(4):2004315. https://doi.org/10.1183/13993003.04...

 Abdominal Tuberculosis : Experience from Two Tertiary-Care Hospitals in the Paris Region. Calin R, Belkacem A, Caraux-Paz P, Wagner M, Guillot H, Veziris N, Jaureguiberry S, Caumes E, Patey O, Pourcher V. Am J Trop Med Hyg. 2021 Jan ;104(1):223-228. https://doi.org/10.4269/ajtmh.20-0023

- The coming-of-age of bedaquiline : a tale with an open ending. Guglielmetti L, Varaine F. Eur Respir J. 2021 Jun 10 ;57(6):2100066. https://doi.org/10.1183/13993003.00...

 Evidence-based Definition for Extensively Drug-resistant Tuberculosis. Roelens M, Battista Migliori G, Rozanova L, Estill J, Campbell JR, Cegielski JP, Tiberi S, Palmero D, Fox GJ, Guglielmetti L, Sotgiu G, Brust JCM, Bang D, Lange C, Menzies D, Keiser O, Raviglione M. Am J Respir Crit Care Med. 2021. https://doi.org/ 10.1164/rccm.202009-3527OC

 TB research requires strong protections, innovation, and increased funding in response to COVID-19. Nyang’wa BT, LaHood AN, Mitnick CD, Guglielmetti L. Trials. 2021 May 29 ;22(1):371. https://doi.org/10.1186/s13063-021-05331

 Use and impact of molecular methods for detecting drug-resistant TB. Molina-Moya B, Guglielmetti L, Bothamley G, van Leth F, Lange C, Dominguez J. Int J Tuberc Lung Dis. 2021 Feb 1 ;25(2):157-159. https://doi.org/10.5588/ijtld.20.0527

 Cardiac safety of multidrug-resistant tuberculosis treatment : moving towards individualised monitoring. Hewison C, Guglielmetti L. Lancet Infect Dis. 2021 Feb 12:S1473-3099(20)30836-7. https://doi.org/10.1016/S1473-3099(20)30836-7

 Rapid molecular diagnosis of tuberculosis and its resistance to rifampicin and isoniazid with automated MDR/MTB ELITe MGB® assay. V. Ok, A. Aubry, F. Morel, I. Bonnet, J. Robert, W. Sougakoff. Antibiotics 2021. https://doi.org/10.3390/antibiotics...

 Targeted next-generation sequencing : a Swiss army knife for mycobacterial diagnostics ? M. S, Köser CU, Salfinger M, Sougakoff W, Heysell SK. Eur Respir J. 2021 ;57(3):2004077. https://doi.org/10.1183/13993003.04...

 Use of a whole genome sequencing-based approach for Mycobacterium tuberculosis surveillance in Europe in 2017-2019 : an ECDC pilot study. Tagliani E, Anthony R, Kohl TA, de Neeling A, Nikolayevskyy V, Ködmön C, Maurer FP, Niemann S, van Soolingen D, van der Werf MJ, Cirillo DM ; ECDC molecular surveillance project participants. Eur Respir J. 2021 ;57(1):2002272. https://doi.org/10.1183/13993003.02...

 A systematic review of Mycobacterium leprae DNA gyrase mutations and their impact on fluoroquinolone resistance. Chauffour, A ; Morel, F ; Reibel, F ; Petrella, S ; Mayer, C ; Cambau, E ; Aubry, A. Clin Microbial Infect 2021.

 Mycobacterium chimaera genomics with regard to epidemiological and clinical investigations conducted for the open-chest post-surgical Mycobacterium chimaera infections outbreak. E. Lecorche, C. Daniau, K. La, F. Mougari, H. Benmansour, S. Kumanski, J. Robert, S. Fournier, G. Lebreton, A. Carbonne, E. Cambau on the behalf of CNR-MyRMA. Open Forum Infect Dis 2021 ; https://doi.org/10.1093/ofid/ofab192

2021 / 2020 / 2019 / 2018 / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008 / 2007 / 2006 / 2005 / 2004 / 2003